# reload+after+2024-01-22 12:43:23.385609
address1§17 Hanover Square
city§London
zip§W1S 1BN
country§United Kingdom
phone§44 20 8092 9299
fax§44 20 3928 8277
website§https://www.aptorumgroup.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A. The company is also developing ALS-2/3 for the treatment of gram+ve bacterial infections; RPIDD, a pathogen molecular diagnostic; NativusWell DOI (NLS-2), a dietary supplement; NLS-1 for the treatment of endometriosis; DLS-1+2 to treat NSCLC with mutation; DLS-3, an autoimmune small molecule; and CLS-1 for the treatment of obesity. Its pipeline products enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platforms for treatment of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. The company was formerly known as APTUS Holdings Limited and changed its name to Aptorum Group Limited in October 2017. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom. Aptorum Group Limited is a subsidiary of Jurchen Investment Corporation.
fullTimeEmployees§18
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Chung Yuen  Huen', 'age': 43, 'title': 'Founder, CEO & Non-Executive Director', 'yearBorn': 1980, 'fiscalYear': 2022, 'totalPay': 923656, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Martin  Siu', 'age': 44, 'title': 'Head of Finance', 'yearBorn': 1979, 'fiscalYear': 2022, 'totalPay': 87344, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.01
priceToSalesTrailing12Months§9.630891
currency§USD
dateShortInterest§1702598400
forwardEps§-0.71
exchange§NCM
quoteType§EQUITY
shortName§Aptorum Group Limited
longName§Aptorum Group Limited
firstTradeDateEpochUtc§1545143400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§4d5340b6-46d9-323c-9b3b-df42182658d0
gmtOffSetMilliseconds§-18000000
recommendationMean§2.0
recommendationKey§buy
quickRatio§0.423
grossMargins§0.07327
ebitdaMargins§0.0
trailingPegRatio§None
